Keyphrases
Colombians
100%
Next-generation Sequencing
77%
Clopidogrel
76%
Pharmacological Analysis
58%
Platelet Reactivity
46%
Polymorphism
43%
COVID-19
36%
High On-treatment Platelet Reactivity
36%
Colorectal Cancer
36%
Acute Coronary Syndrome
34%
CYP2C19
34%
Functional Analysis
34%
Breast Cancer
34%
Allele Frequency
33%
Mayors
32%
Molecular Variants
31%
Breast Cancer Susceptibility Gene 1 (BRCA1)
29%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
29%
Pathogenic Variants
29%
Population Genetics
27%
Inter-individual Variability
25%
Adverse Drug Reaction
25%
Genetic Approach
23%
MicroRNA
23%
3′-untranslated Region (3′-UTR)
23%
Pharmacogenetic Study
23%
New Risks
23%
Molecular Analysis
23%
Genetic Profile
21%
Genetic Risk
21%
Colombia
21%
Whole Exome Sequencing
20%
Clopidogrel Response
19%
Colombian Patients
19%
Closure Time
18%
Single nucleotide Polymorphism
18%
Pharmacogenomics
17%
Genetic Factors
17%
Non-genetic Factors
17%
Molecular Variation
15%
Rare Variants
14%
Functional Validation
13%
Antiplatelet Drugs
13%
Pharmacogenetic Variants
13%
TFL1
13%
Adverse Reactions
13%
Latin American Populations
13%
Antiplatelet Therapy
12%
Value of Time
12%
Risk Score
12%
Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
95%
Clopidogrel
89%
Pharmacogenetic Testing
87%
Genetics
54%
Allele
48%
Platelet Reactivity
48%
Exome Sequencing
39%
Gene Frequency
38%
Genetic Determinism
37%
BRCA1
34%
Population Genetics
32%
CYP2C19
30%
Genomics
28%
Reporter Gene
27%
Luciferase
27%
Genetic Risk
26%
Germline
23%
Germ Cell
23%
Genetic Approach
23%
T Cell
23%
Transcription Factor
23%
Electrophoretic Mobility Shift Assay
23%
Pharmacogenetics
21%
Missense
20%
MicroRNA
18%
SARS Coronavirus
18%
Metabolic Pathway
17%
Single-Nucleotide Polymorphism
17%
Promoter Region
17%
Pharmacogenomics
15%
CYP2C9
14%
Pharmacogenetic Variant
13%
Genetic Divergence
12%
BRCA2
11%
Lymphoid Enhancer-Binding Factor 1
11%
Cancer Immunotherapy
11%
Artificial Intelligence
11%
Coronavirinae
11%
Aryldialkylphosphatase
11%
Paraoxonase
11%
VKORC1
11%
Neuromuscular Blocking
11%
Cholinesterase
11%
K-Complex
11%
Suxamethonium Chloride
11%
Gene Expression
11%
Genetic Variation
11%
Tumor Escape
11%
Binding Site
11%
Case-Control Study
11%